T1	Participants 43 123	female patients undergoing curative adjuvant irradiation following breast cancer
T2	Participants 574 669	50 patients submitted to curative adjuvant irradiation following surgery for mammary carcinoma.
T3	Participants 846 857	study group
T4	Participants 911 924	control group
